ArticlePsychiatry investigation2026
Exploring the Characteristics of Individuals Grouped Based on the Multimodal Optimized Treatment for Insomnia Framework Among Individuals Complaining of Insomnia.
Article in Psychiatry investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development of Sleep medications MYTH-understanding (SMYTH) and Sleep Medications Overexpectation of REsponses (SMORE) among the general population.Sleep & breathing = Schlaf & Atmung · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
objectiveThis study aimed to explore the feasibility of the Multimodal Optimized Treatment for Insomnia Framework (MOTIF) among people with insomnia symptoms among the general population.
methodsAn online survey among people in the general population complaining of insomnia was conducted anonymously. Participants were categorised into two groups based on 6 hours of time in bed (TIB). Each group was further clustered into two groups based on favourable attitudes toward taking hypnotics. Their psychological states were assessed using the Insomnia Severity Index (ISI), Patient Health Questionnaire-9 (PHQ-9), Dysfunctional Beliefs and Attitudes about Sleep-6 (DBAS-6), Adaptive Cognition and Behaviors about Sleep-6 (ACBS-6), and Depressive Symptoms Inventory-Suicidality Scale (DSI-SS).
resultsThere were 600 responses collected, with 548 responses analysed from people whose bedtime was between 9:00 PM and 1:00 AM. In total, 86.1% were categorized as individuals who can sleep without medications, while 13.9% as individuals who cannot. The ISI score was significantly higher among individuals with TIB ≤6 hours. Based on the attitude toward taking hypnotics, the proportions of participants in each category were 46.9%, 39.2%, 7.8%, and 6.0%. The ISI and DSI-SS scores (18.7±5.3 and 2.9±2.6, respectively) were significantly higher among the group who cannot sleep without medications and who had a favourable attitude to taking hypnotics. The proportion of participants taking hypnotics was lowest among the group who cannot sleep without medications and had an unfavourable attitude to taking hypnotics.
conclusionIndividuals unable to sleep without hypnotics exhibit more severe insomnia symptoms and higher psychological distress.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.